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To avoid unsuspected and unwanted consequences of excess 
hapten during epicutaneous sensitization, optimal sensitizing 
doses of dinitrofluorobenzene (DNFB) were determined for 
several ultraviolet E radiation (UVE) - resistant and UVE-
susceptible strains of mice. U sing these doses of hapten ap-
plied epicutaneously or injected intracutaneously into nor-
mal or UVE-exposed body wall skin, it was determined that 
four consecutive daily exposures to UVE prevented contact 
hypersensitivity induction in all mice when optimal sensitiz-
ing doses ofDNFE were applied epicutaneously. Ey contrast, 
UVE-resistant, but not UVE-susceptible, mice developed 
contact hypersensitivity when an optimal sensitizing dose of 
DNFE was injected intracutaneously into UVB-irradiated 
skin. Moreover, w hereas UVE-susceptible mice failed to de-
T he capacity of acute, low-dose ultraviolet B irradiation (UVB) to impair the induction of contact hypersensi-tivity (CH) in mice has been found to be genetically determined by polymorphic alleles at the TuJa and Lps loci [1] . Most inbred strains of mice are susceptible 
to the deleterious effects of UVB on CH induction (designated 
UVB susceptible), i.e., they fail to develop CH when dinitroAuoro-
benzene (DNFB) is painted on UVB-exposed skin. However, 
strains that are homozygous with respect to the TuJad or LpSd alleles 
are UVB resistant, i.e., they develop CH when DNFB is painted on 
UVB-exposed (as well as unexposed) body wall skin. Discovery of a 
genetic basis for the effects of UVB on cutaneous immunity is 
thought to be important in part because 1) the traits ofUVB suscep-
tibility and UVB resistance have been demonstrated in humans, and 
2) individuals with the UVB-susceptibility phenotype are prone to 
develop sunlight-induced skin cancers [2]. 
It was demonstrated many years ago that epidermal Langerhans 
cells (LC) are sensitive to UVB radia tion [3]. The original proto-
col of acute, low-dose UVB irradiation used to study CH was de-
signed to eliminate LC from the skin, thereby making it possible 
to test whether these cells are essential in the induction of 
CH to epicutaneously applied haptens [4]. Although four consecu-
tive daily exposures to UVB radiation (400 J/m2) impairs CH in-
duction onl y in UVB-susceptible mice, this protocol profoundly 
red uces the LC content of epidermis in all strains of mice, whether 
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velop contact hypersensitivity when an optimal sensitizing 
dose ofDNFB was painted on skin exposed to a single dose of 
UVE, UVE-resistant mice did develop contact hypersensi-
tivity under similar circumstances. Based on these results, it is 
concluded that 1) conventional doses of epicutaneously ap-
plied haptens induce contact hypersensitivity with the aid of 
antigen-presenting cells derived from both the epidermis and 
the dermis, 2) the phenomenon ofUVE susceptibility is me-
diated by cells and molecules within the dermis when con-
ventional doses of hapten and UVE radiation are employed, 
and 3) UVE susceptibility is mediated by cells and molecules 
within the epidermis when optimal sensitizing doses ofhap-
ten and a single exposure to UVE are employed. ] Il1 vest 
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UVB susceptible or UVB resistant [5] . We have inferred from 
these findings that the relevant antigen-presenting cells respon-
sible for CH induction after UVB radiation in UVB-resistant 
mice are not LC, but undesignated cells located outside the 
epidermis - presumably in the dermis [6]-and it is generally be-
lieved the dermis is beyond the reach of UVB rad iation [7] . The 
identification of the putative dermal antigen-presenting cells and 
their potential roles in CH induction, as well as hapten-specific 
tolerance, are important to our understanding of cutaneous immu-
nobiology. 
Sullivan e/ al have recently reported that conventional doses of 
hapten used for CH induction in mice are excessive [8]. This report 
as well as others [9] demonstrated that the amount of epicutaneously 
applied DNFB or trinitrochlorobenzene needed to induce CH in 
mice is at least 10 times less than the amount typically used in 
experiments of this type. It is likely that excess hapten in the con-
ventional immunizing protocols unduly complicates the sensitizing 
process, and may actually promote suppression and down-regula-
tion of the C H response. W e have therefore adopted the approach 
of Sullivan et al in limiting the amount of sensitizing hapten to the 
minimum that is required to induce CH, and we have termed th is 
amount of hapten the "optimal sensitizing dose." Using this dose in 
various inbred strains of mice (both UVB susceptible and UVB 
resistant), we have examined the effects of acute, low-dose UVB 
radiation on the induction of CH and tolerance following epicu-
taneous and intracutaneous administration of DNFB. The results 
indicate that all mice are UVB susceptible if only an optimal sensi-
tizing dose of hapten is applied to skin after the conventional acute, 
low-dose regimen of UVB. Moreover, none of these mice develop 
hapten-specific tolerance. However, when the amount of UVB ra-
diation is significantly reduced and an optimal sensitizing dose of 
hapten is applied epicutaneously the genetically determined traits of 
UVB susceptibility and UVB resistance are once again distinguish-
able. 
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Figure 1. Delineation of optimal sensitizing doses of epicutaneously applicd DNFB in BALB/c a,b) and C57BL/6 (c) mice. Pancls of mice (five each) 
received designated amounts ofDNFB diluted in acetone (25 ,ul) applied to shaved abdominal skin. After 5 d, the ears of these mice were challenged with 20,u1 
of DNFB (59 ,ug) and the amount of car swelling measured 24 h latcr. Values presented arc mean ± SEM (urn). 
MATERIALS AND METHODS 
Mice Adult mice (8 - 16 weeks of age) of the following inbred strains were 
obtained from our domestic breeding facility or purchased from Jackson 
Laboratories, Bar Harbor, ME: BALB/c, BIO.A, DBA/2 (designated as 
UVB resistant) and C57BL/6, C3H/HcN (designated as UVB susceptible) 
[5] . Experimental procedures were carried out with the animals under gen-
eral anesthesia achieved by intraperitoncal injection of pcntobarbital. Each 
control or experimcntal panel consisted of five mice. 
Induction and Assay of Contact Hypersensitivity Dinitrofluorobcn-
zene (25,u1 of 0.04% [15 ,ug] or 0.004% [1.5 ,ugJ) in acetonc was applied to 
the dry shaved abdominal cutaneous surface of mice (epicutancous scnsitiza-
tion). In other experiments, 100,u1 of the dose of DNFB in acetonc, phos-
phate-buffered salinc 1 : 10 was injectcd intracutaneously into the dry shaved 
abdominal skin on day 0, as previously described [1]. Contact hypersensitiv-
ity was el icited on day 5 by challenging one car of each mouse with 20,u1 of 
0.2% DNFB (59 pg). Ear thickness was measured with an engineer's mi-
crometer 24 and 48 h following challenge and compared with car thickness 
prior to challenge. 
Radiation Thc shaved abdominal skin was exposed to UVB from a bank 
of four FS-20 fluorescent lamps with a tube to target distance of 46 cm, as 
previously described [4,5]. These bulbs have a broad emission spectrum 
(250-400 nm), and high output was primari ly in the UVB range (290 -320 
nm). As measured by an lL 700 radiometer with a SEE 240 UVB photode-
tector, these lamps delivered an average flux of 1.7 J/m2/second. Mice were 
exposed to UVB daily for four consecutive days (400 J/m2/d). Other panels 
of mice were exposed to UVB for only 1 day. Within 30 min of the final 
exposure, DNFB was applied to the irradiated site or injected intracutane-
ously into the site. 
Intracutaneous Injections Using a 1.0-ml syringe with a 30-gauge nee-
dle, inoculations were placed in the intracutaneous space as described previ-
ously [1] . Successful inoculations were characterized by the appearance of a 
dome-shaped swel ling beneath the epidermis. 
Statistical Evaluation The statistical significance of differences in the 
means of each experimental group was calculated by the Student t test. Mean 
differences were considered significant when p < 0.05. 
RESULTS 
Optimal Sensitizing Doses of DNFB in Various Strains of 
Mice Panels of mice representing inbred strains BALB/c, DBA/ 
2, BI0.A, C57BL/6, and C3H/HeN received graded doses of epi-
cutaneously applied DNFB in acetone to shaved abdominal skin to 
determine the "optimal sensitizing dose," i.e., the dose of hapten 
that induces vigorous CH that can be detected on ear chall enge with 
dilute DNFB 5 d later. The range of doses started at the highest, 25 
III of 0.5% DNFB (185I1g), and ended at the lowest, 25111 (0.3I1g)· 
The results of typical dose-response experiments for BALB/c and 
C57BL/6 mice are displayed in Fig 1. It can be seen that the optimal 
sensitizing dose for BALB/c mice is 1.5 Jlg DNFB, because the CH 
response of BALB/c mice exposed epicutaneously to 25 III of 0.75 
Ilg DNFB was indistinguishable statistically from the ear-swelling 
response of unsensitized contro l mice. N ote that the CH response of 
mice sensitized epicutaneously with 1511g (as well as higher) doses 
of DNFB was somew hat more intense than the CH response in-
duced by the optima l sensitizing dose, 25111 of 1.5 I1g. A similar 
pattern of responses w as detected among C57BL/6 mice, with 25111 
of epicutaneously applied 1.5 Jlg DNFB inducing subsequent ear-
swelling responses that were significantly greater than the responses 
induced by 0.311g DNFB; these latter responses were indistinguish-
able from the negative contro l (Fig I c). The results of dose-response 
experiments for all tested strains are summarized in Table 1. With 
the exception of DBA/2 mice, animals responded to epicutaneous 
application of25 111 of 1.511g DNFB on abdominal skin by develop-
ing intense CH, which is regarded as an optimal sensitizing dose. 
For DBA/2 mice, the optimal sensitizing dose was 1511g DNFB. 
The optimal sensitizing dose of DNFB, as we have defined it, is 
significantly less (at least by a factor of to) than the amount of 
DNFB typica lly used to induce CH in mice (18511g or greater). We 
conclude that conventional sensitizing procedures are carried out in 
considerab le hapten excess. 
It has been reported recently that intracutaneous i~ection of hap-
ten leads to CH induction similar to that induced by epicutaneous 
hapten application [6]. It is presumed that the relevant antigen-pre-
senting cells following intracutaneous injection of hapten reside 
within the dermis (and/or the draining lymph node), rather than 
within the epidermis. The precise identity of these cells is obscure, 
although both dermal dendritic cells and macrophages are candi-
dates [10] . We next determined whether the optimal sensitizing 
dose of DNFB, defined in the previous experiments, was capable of 
inducing CH in mice if th e hapten was injected intracutaneously. 
Panels of each of these strains of mice received an optimal sensitiz-
ing dose of DNFB (as defined epicutaneously) by intracutaneous 
injection. Five days later their ears were challenged with 20111 of 
0.2% DNFB. As the results presented in T able II reveal, CH was 
induced in mice of each strain when an optimal sensitizing dose of 
DNFB was injected intraclltaneously. Moreover, the intensity of 
these responses was simil ar to that induced by epicutaneous applica-
tion of the same doses of hapten. 
Based on these findings, we hypothesize that treating murine skin 
Table I. Optimal Sensitizing Doses of DNFB 
in Various Strains of Mice" 
Strain 
BALB/c 
DBA2 
BI0.A 
C57BL/6 
C3H/HeN 
Dose (Ilg/25 pi) 
1.5 
15.0 
1.5 
1.5 
1.5 
• Doses tested include 185/ig, 37 ~lg, 15 jig, \.5 pg, and 0.3 jig/per application to 
shaved abdominal skin. 
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Table II. C H Response of Mice After Intracutaneous 
Injection of Optimal Sensitizing Dose of DNFE 
Strain 
BALB/c 
DBA.2 
BI0.A 
C57BL/6 
C3H/HeN 
Ear-Swel ling Response 
(X 1 11m ± SEM) 
Control Injection' 
23.2 ± 8.2 113.5 ± 14.5 
22.2 ± 6.8 129.6 ± 17.5 
41.2±2.5 127.8 ± 13.2 
9.0 ± 2.5 107.8 ± 15.6 
18.5 ± 8.2 90 ± 9.4 
• Optimal se nsitizing dose ofDNFB injected intracutaneously into abdominal skin (Sec 
Table I). 
epicutaneously or intracutaneously :-vith a .so-called ."optimal sensi-
tizing dose" ofDNFE leads to CH mductlOn m wl11ch the relevant 
antigen presenting cells are located, respectively, either solely 
within the epidermis (LC) or solely within the dermis. We further 
propose that under these circumstances little or no excess hapten is 
avail able to derivatize potentially immunogenic molecules or cells 
at sites distant from the skin. The next experiments address in part 
these hypotheses. 
Conventional Acute, Low-Dose UVB Regimen Acute, low-
dose UVE radiation, according to the regimen we and others have 
used for more than 10 years (four consecutive daily exposures to 400 
J /m2) , depletes the murine epidermis of virtually all LC. In addi-
tion, a dermal inflammation is induced at the irradiated site, indicat-
ing that a significant amount ofUVE radiation reaches the dermis, 
and/or that mediators released from UVE-damaged epidermal cells 
cause a dermal infl ammatory response. Irrespective of the cause of 
dermal infl ammation, inflammatory cells in the dermis at the time 
hapten is applied makes it difficult to know whether conventional 
doses (excessive) of epicutaneously applied haptens induce sensiti-
zation in UVE-resistant mice by derivatization of epidermal and/or 
dermal anti gen-presenting cells. To examine this question, panels 
of three UVE-resistant mouse strains [DEA/2, EALE/c, EI0.A) 
and two UVE,susceptible strains (C57EL/6, C3H/HeN)) received 
four daily doses of UVE to shaved abdominal skin. Immediately 
thereafter, an optimal sensi tizing dose of DNFE was applied to the 
irradiated site. The ears of these mice were challenged 5 d later. A 
summary of the ear-swelling responses is presented in Table III. As 
expected, an optimal sensitizing dose of DNFE applied epicu-
taneously to UVE-exposed skin of the UVE-susceptible mice in-
duced only feeble CH. However, the same results were observed 
among UVE-resistant mice that received an optimal sensitizing 
dose of DNFE via UVE-exposed skin, i.e., these mice displayed 
significantly less intense C H than their rositive controls . Thus, 
when an optimal (non-excessive) dose 0 epicutaneously applied 
Table III. Effect of Four Doses of UVE Radiation on 
Induction of CH to Epicutaneous Application of an 
Optimal Sensitizing Dose of DNFE in UVE-resistant 
and UVE-susceptible Mice 
Ear-Swel ling Response (X 111m ± SEM) 
Negative Positive % 
Strain Controls Controls 4 X UVB' Reductionb 
BALB/c 13.8 ± 3.1 73.2 ± 11.2 37.4 ± 6.4 60 
DBA.2 47.2±13.1 142.0 ± 12.9 86.0 ± 8.6 61 
BlO.A 40.0 ± 10.0 137.6 ± 11.5 64.0 ± 10.7 75 
C57BL/6 9.0 ± 2.5 99.2 ± 13.0 23.2 ± 5.9 84 
C3H/HeN 18.5 ± 8.2 87.6 ± 8.5 17.0 ± 6.7 108 
• Optimal sensitizing dose of DNFB applied cpicutaneously after last oHour succes· 
sive days of UVB irradiation to abdominal skin. 
• % reduction = <lear swelling (positive controls) - car swelling (experimental)J/ 
lcar.swclling (positive controls) - car swelling (negative controls)]) X 100%. 
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Table IV. Effect of Four Doses of UVE Radiation on 
Induction of CH to Intracutaneous Injection of an 
Optimal Sensitizing Dose of DNFE in UVE-Resistant 
and UVE-Susceptible Mice 
Ear-Swelling Response (X 111m ± SEM) 
Negative Positive % 
Strain Contro ls Controls 4 X UVB' Reductionb 
BALB/c 23.2 ± 8.2' 113.5 ± 14.5 123 .0 ± 23.5 -10 
DBA.2 2.2 ± 6.8' 129.6 ± 17.5 115.2 ± 8.0 13 
BI0.A 41.2 ± 2.5' 127.8 ± 13.2 118.8 ± 10.1 10 
C57BL/6 9.0 ± 2.5' 107.8 ± 15.6 26.2 ± 9.9' 83 
C3H/HeN 18.5 ± 8.2' 90.0 ± 9.4 44.4 ± 10.3' 64 
'Optimal sensitizing dose of DNFB injected intracutaneollsly after the last of 4 
successive days exposures of UVB irradiation to abdomina l skin. 
• % reduction calculated as described in Table III 
, Indicates value significantly lower than positive control. 
DNFE is painted on UVE-treated skin, all mice fail to develop CH, 
or do so poorly, i.e., they appear to be UVE susceptible. These 
findings indicate that the phenotypes of UVE susceptibility and 
UVE resistance, as previously defined in mice, are ac tually predi-
cated on the amount of hapten used during sensitization. UVB 
resistance is only evident in certain strains of mice that receive an 
excess of DNFE on UVE-exposed skin. 
In companion experiments, similar panels of UVE-resistant and 
UVE-susceptible mice received an optimal sensitizing dose of 
DNFE injected intracutaneously into UVE-treated skin, within 30 
min of the fourth exposure. The ear-swelling responses of these 
mice assayed 5 d later are summarized in Table IV. Contact hyper-
sensitivity responses displayed by UVE-exposed, UVE-susceptible 
strains of C57EL/6 and C3H/HeN were poor, compared to posi-
tive syngeneic controls that received an intracutaneous injection of 
an optimal sensitizing dose of DNFE into normal body wall skin. 
Ey contrast, CH responses elicited in the UVE-exposed, UVE-re-
sistant strains were strong and statistically comparable in intensity to 
the responses of positive controls sensitized with an optimal sensi-
tizing dose of DNFE injected intracutaneously into normal skin. 
Thus, the UVE-dependent phenotypes of UVE susceptibility and 
UVE resistance, previously defined with the use of excessive 
amounts of epicutaneously applied DNFE [1), are readily apparent 
when an optimal sensitizing dose of DNFE is injected intracutane-
ously into UVE-exposed skin . Eecause we have hypothesized that 
only dermal antigen-presenting cells participate in CH induction 
following intracutaneous injection of an optimal sensitizing dose of 
DNFE, these experimental results imply that the relevant antigen-
presenting cell targets of UVE radiation that are responsible for the 
UVE-susceptible and UVE-resistant phenotypes are located ill the 
dermis, rather than the epidermis. This implication is consistent 
with the fact that virtually all LC are obliterated by this acute, 
low-dose regimen ofUVE radiation in all strains of mice. Thus, the 
molecular mechanisms responsible for the phenotypes of UVE re-
sistance and UVE susceptibility appear to operate at the level of the 
dermis, rather than the epidermis -at least when the typical acute, 
low-dose UVE regimen is used. 
Minimal, Acute, Low-Dose UVB Radiation Whereas four 
consecutive daily doses of 400 J / m2 UVE rad iation eliminate al-
most all normal appearing LC from murine epidermis, less intensive 
UVE regimens produce less drastic effects on them. We have previ-
ously reported that a single exposure of murine skin to 400 J /m2 
UVE radiation reduces the number of class II major histocompati-
bility complex-bearing cells by approximately 20-30%, and the 
remaining cells display an altered morphology; the cell bodies are 
swollen and rounded, the dendrites are fewer in number, and the 
dendrites that remain are generally short and stubby [11] . These 
changes are quantitatively more severe in UVE-exposed epidermis 
of UVE-susceptible mice, compared with their UVE-resistant 
counterparts . It seemed appropriate to attempt to sensitize mice 
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Table V . Effect of Single Dose of UYB Radiation on Induction 
of CH to Epicutaneous Application of an Optimal Sensitizing 
Dose of DNFB in UYB-Resistant and UYB-Susceptible Mice 
Ear-Swelling Response (X 1 pm ± SEM) 
Negative Positive % 
Strain Controls Controls 1 X UVB' Reductionb 
BALB/c 13.2 ± 3.1 ' 73.2 ± 11.2 65.6 ± 12.9 13 
DBA.2 47.2 ± 13.1' 142.0.6 ± 12.9 132.8 ± 11.4 10 
BI0.A 40.0 ± 10.0' 137.6 ± 11.5 127.6 ± 16.3 10 
C57BL/6 9.0 ± 2.5' 99.2 ± 13.0 53.2 ± 16.1 ' 51 
C3H/HeN 18.5 ± 8.2' 87.6 ± 8.5 58.2 ± 12.2' 43 
• Optimal sensitizing dose of DNFB injected epicutaneously after a single dose of 
VVll irradiation to abdominal skin. 
b % reduction calculated as described in Table III . 
, Indicates value significantly lower than positive control. 
with an 0Ftimal sensitizing dose ofDNFB after a single exposure of 
body wal skin to UVB. Accordingly, we examined the capacity of 
an optimal sensitizing dose ofDNFB to sensitize BALB/c, DBA/2, 
B 10.A, C57BL/6, and C3H/HeN mice through shaved body wall 
skin that had received a single exposure (400 ]/m2 of UYB radia-
tion). The hapten was applied within 30 min of the cutaneous 
exposure to UYB. When the ears of these mice were challenged 
with DNFB 5 d later, swelling was found to be intense among 
B 1 O.A, DBA/2, and BALBI c mice, and comparable to the intensity 
of positive controls. However, much less intense ear swelling was 
observed among the ears of C57BL/6 and C3H/HeN mice com-
pared to pos itive controls (Table V). These results reveal that, when 
an optimal sensitizing dose of hapten is applied epicutaneously to 
skin that has received a single, small dose ofUYB radiation, vigor-
ous CH is induced Dil ly among strains of mice that have previously 
been described as UYB resistant. If our hypothesis is correct-that 
only epidermal antigen-presenting cells participate in CH induc-
tion when an optimal sensitizing dose of DNFB is applied 
epicutaneously - then these results indicate that the molecul ar 
mechanisms responsible for the UYB-resistant and UYB-suscepti-
ble traits can also be shown to operate within the epidermis. 
In a final set of experiments, we determined whether a single 
exposure of skin to UYB radiation altered sensitization by an intra-
cutaneous injection of hapten. Panels ofUYB-susceptible C57BL/6 
mice received one exposure ofUYB (400 ]/m2) . Shortly thereafter 
(5 and 25 min), an optimal sensitizing dose of DNFB was injected 
intracutaneously into the irradiated site. The ears of these mice, plus 
positive and negative controls, were challenged with di lute DNFB. 
The results are displayed in Fig 2. The intensity of CH elicited in 
ears of positive control mice was similar to (and statistica lly indis-
tinguishable from) that of mice that received DNFB injected into 
the UYB-irradiated site. These findings reveal that the effectiveness 
of sensitization by an optimal sensitizing dose of DNFB delivered 
via the intracutaneous route is undiminished by a single exposure to 
UVB radiation-even in UYB-susceptible mice. Because the ex-
periment above indicates that a single dose of UYB impairs the 
functional activity of epidermal LC, we conclude that a single dose 
of UVB of this intensity has little or no effect on antigen presenta-
tion by dermal cells. Moreover, this outcome suggests that epider-
mal LC are not necessary to sensitization that occurs after hapten is 
injected into the dermis. 
DISCUSSION 
For many years it was thought that contact hypersensitivity to 
high ly reactive chemicals cou ld only be studied in humans and 
gu inea pigs, that mice were unable to display this type of immune 
reactivity, and that, therefore, a proper understanding of the phe-
nomenon wou ld be.difficult to achieve. However, Asherson and his 
colleagues in the late 1960s described an experimental protocol for 
sensitizing mice to severa l haptens, including DNFB, trinitrochlor-
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obenzene, and oxazolone, using a foot pad or ear challenge assay to 
monitor the CH response quantitatively [12) . Since then, numerous 
other reactive chemicals have been used to study CH in mice [13) . 
As anticipated , the creation of this model system has proved to be a 
major boon to the study of cell-mediated immunity. A literature of 
considerable size now exists that describes 1) the central role of 
CD4+ and CD8+ T cells in the induction and expression of CH in 
murine skin, and 2) the roles of subpopulations of T cells in the 
regulation of CH, and in hapten-specific tolerance [14]. 
In cutaneous immunobiology, analysis of CH in mice has been 
pivotal to our understanding of the antigen-presenting cel ls that 
initiate CH, especially epidermal LC. It has been reported that 
epidermal surfaces that are relatively deficient in LC (tail skin) are 
poor at supporting the induction of hapten-specific CH, giving rise 
to the idea that the density of LC in the epidermis is a critical factor 
in the acquisition of immunity to cutaneous antigens [4]. This logic 
led to the use of acute, low-dose UVB radiation as an experimental 
means to deplete normal body wall skin of LC. It was soon learned 
that after this regimen of UVB radiation, hapten application fai led 
to induce CH - at least in certain genetically defined strains of mice 
[4]. What was, and remains, perplexing today is the cellular basis for 
successful CH induction when hapten is applied to UYB-exposed 
skin ofUYB-resistant strains of mice. The dilemma results from the 
knowledge that this regimen ofUYB radiation eliminates virtually 
all LC from the epidermis . 
The results of the experiments comprising this report help to 
resolve this di lemma and to provide important insights into the 
cellular mechanisms responsible for the induction of cutaneous im-
munity and its regulation. It has been clear for some time that the 
amount of hapten used in the original protocols to sensitize mice 
epicutaneous ly is excessive [8,15). Following the lead of Sullivan el 
al (8). we have now defined optimal sensitizing doses of DNFB for 
five different strains of mice. When these doses of DNFB were 
applied epicutaneous ly or injected intracutaneously into skin that 
was normal, or had been exposed to acute, low doses ofUYB radia-
tion, it became possible to reach conclusions and make inferences. 
First, epicutaneous sensitization with an optimal sensitizing dose of 
DNFB relies solely on epidermal LC as antigen-presenting cells. 
This conclusion is based on prior knowledge that four consecutive 
daily doses ofUYB radiation eliminates LC from the epidermis, and 
on our findings that an epicutaneous optimal sensitizing dose of 
DNFB fails to sensitize either UYB-susceptible or UYB-resistant 
mice if the skin has received the same acute, low-dose UYB regi-
men. It follows that when conventional sensitizing doses of hapten 
are applied epicutaneously, both dermal and epidermal cell s must 
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Figure 2. Induction of CH with an optimal sensitizing dose of DNFB 
injected intracutaneously in skin of C57BL/ 6 mice 5 and 25 min after a 
single exposure to UVB radiation (400 ) / m2). Positive controls received an 
optimal sensitizing dose of DNFB intracuraneously in unirradiated skin. 
Ears were challenged with 20 pI DNFB (59 pg) after 5 d, and swel ling 
responses at 24 and 48 h are presented as mean ± SEM (pm). 
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participate in antigen presentation. Second, following four daily 
exposures of mouse skin to UYB radiation, only non-epidermal 
antigen presenting cells participate in CH induction in UVB-resis-
tant mice, whether an optimal sensitizing dose of hapten is injected 
intracutaneously or a conventional dose of hapten is applied epicu-
taneously. On the assumption that th ese inferences are correct, it is 
reasonable to state that the reason that UVB-resistant mice become 
sensitized when conventional doses ofDNFB are painted on UVB-
exposed (LC depleted) skin is that dermal cells (resident dermal 
dendrocytes or macrophages? recruited monocytes/macrophages?) 
retain their antigen-presenting capabilities, even though UVB has 
significan tly altered the cutaneous microenvironment. The resist-
ance ofUVB-resistant mice that is expressed in this manner may be 
related to polymorphic allel es at the T,ifa locus (BALB/c, DBA/2, 
BIO.A mice) and/or the Lps locus (C3H/HeJ mice), respectively 
[1] . In both circumstances, factors that limit transcriptional or trans-
lational efficiency of mRNA for tumor necrosis fac tor (TN Fa) are 
believed to confer the UVB-resistance phenotype, presumably by 
limiting intracutaneous production of TNFa in response to UVB 
radiation . Strong circumstantial evidence implicates excess TNFa 
production or availability in UVB-exposed skin ofUVB-susceptible 
mice as the mediator that prevents sensi tization when hapten is 
applied epicutaneously [1] . 
It is of interest to consider the identity of the dermal antigen-pre-
sentin g ce lls that we postu late to participate in CH induction in 
UVB-resistant mice when four consecutive doses ofuVB radiation 
have depleted the epidermis of LC. Tse and Cooper have demon-
strated that Ia+ cell s of bone marrow origin exist in murine dermis 
and can function to activate delayed hypersensitivity [16]. Dermal 
dendritic cells and macrophages have recently been reviewed in 
considerable detail with regard to their role(s) in the so-called "der-
mal immune system" [17] , but description of this system is still in its 
infancy. Our data do not permit us to distinguish whether the rele-
vant dermal antigen-presenting cell is a dendrocyte, a macrophage, 
a precursor LC, or perhaps some other, as yet unidentified, ce ll. 
Cooper et al [1 8] have discovered that antigen-presenting melano-
phages (presumably of dermal origin) appear in human epidermis 
after UVB radiation, and Baadsgaard et al [19] have reported that 
ce lls of this type after UVB radiation acquire the capacity to func-
tion as suppressor-inducing antigen-presenting cells. Whether sim-
ilar changes take place among dermal macrophages in murine skin 
following UVB radiation is unknown. In that context, our evidence 
indicates that, in UVB-resistant mice, cells capable of promoting 
CH exist within the dermis following UVB radiation. Perhaps the 
UYB-resistance phenotype occurs in genetically defined mice that 
fail to acquire dermal suppressor-inducer antigen-presenting cells in 
response to UVB radiation. 
We were concerned to discover that the UVB susceptibility and 
UYB resistance phenotypes of mice disappeared when the amount 
of hapten applied epicutaneously to UVB-irradiated skin was re-
duced to the optimal sensitizi ng dose. On further consideration, our 
studies with single exposures to UVB reveal that the phenotypes of 
UVB susceptibility and UVB resistance are real, but that their reli-
able identification depends on both the amount of hapten painted 
on the epidermal surface, and the amount of UVB radiation that 
precedes the application of hapten. At conventional sensitizing 
doses of DNFB, and with an acute low-dose protocol that includes 
four consecutive daily exposures to UVB, the traits of UVB suscep-
tibility and UVB resistance exist and th e cellular and molecular 
mechanisms that are invoked appear to operate at the level of the 
dermis. By contrast, when an optimal sensitizing dose of DNFB is 
painted epicutaneously, the traits of UVB susceptibility and UVB 
resistance arc discernible only if a single, low-dose exposure ofUVB 
immediately precedes the application of hapten. In this instance, the 
evidence suggests that UVB susceptibility resu lts fro m intraepider-
mal events, presumably when UVB radiation induces the release of 
an excessive amount of TNFa from keratinocytes, which in turn 
impairs the capacity of epidermal LC to initiate CH induction to the -
hapten [11] . The finding that vigorous CH was induced if an opti-
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mal sensitizing dose of hapten was il~ected intracutaneously into 
skin irradiated with a single UVB exposure indicates that when the 
microenvironmental changes wrought by UVB radiation are lim-
ited to the epidermis, se nsitization via dermal antigen presentation 
pathways remains intact. 
We suspect, but have no direct know ledge, that the reason opti-
mal sensitizing doses of hapten are so informative is that at tillS 
dosage level hapten derivatization of epsilon-amino groups oflysme 
residues on proteins in the immediate microenvironment proceeds 
to completion, i.e., hapten is completely "used up" in the process of 
derivatizing proteins within the epidermis (after epicutaneous ap-
plication) or the dermis (after intracutaneous injection). We suspect 
that it is important immunologically for all hapten to be covalently 
bound to local proteins in these circumstances, because no free hap-
ten wi ll then exist that can diffuse to distant si tes (blood stream, 
draining lymph node) w here tolerance and regulation of CH is 
initiated and mediated. Experiments to test these latter suspicions 
are currently underway. 
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